Fentanyl is a WMD Act

Bill Number

H.R. 128

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Emergency Management

Status

Introduced

Latest Action

2025-01-03: Referred to the Subcommittee on Emergency Management and Technology.

Last Updated

2026-06-04T08:08:49Z

AI-Generated Summary

Purpose of the Legislation

The "Fentanyl is a WMD Act" (H.R. 128) aims to address the opioid crisis by classifying illicit fentanyl—a highly potent synthetic opioid drug—as a weapon of mass destruction (WMD). This reclassification would allow the Department of Homeland Security (DHS) to apply its existing counter-WMD strategies to combat fentanyl trafficking and distribution, treating it similarly to threats like chemical or biological weapons that can cause widespread harm.

Key Provisions

• Mandatory Treatment as WMD: The Assistant Secretary for the Countering Weapons of Mass Destruction Office (CWMD) within DHS must treat illicit fentanyl as a WMD under Title XIX of the Homeland Security Act of 2002 (which covers programs to prevent and respond to WMD threats).
• Scope: This applies specifically to illicit (illegally produced or distributed) fentanyl, enabling the use of CWMD resources for detection, prevention, and mitigation efforts.

Significant Changes to Existing Law

• Expands the application of Title XIX of the Homeland Security Act (6 U.S.C. 590 et seq.), which previously focused on traditional WMDs such as nuclear, radiological, biological, or chemical weapons.
• Introduces a novel categorization of a drug as a WMD, shifting fentanyl from primarily a public health and drug enforcement issue to one framed under national security and counter-terrorism frameworks. No other substantive amendments to the Act are specified.

Potential Impacts

• On Government Agencies: Enhances DHS's CWMD office authority and resources to tackle fentanyl, potentially improving coordination with other agencies like the Drug Enforcement Administration (DEA) or Customs and Border Protection for border security and intelligence sharing.
• On Citizens: Could lead to stronger federal efforts to reduce fentanyl-related overdoses (which cause thousands of deaths annually), but might also increase surveillance or enforcement in communities affected by drug trafficking.
• On International Relations: May intensify U.S. pressure on countries involved in fentanyl production (e.g., via diplomacy or sanctions), viewing trafficking as a security threat rather than solely a health issue.

Main Stakeholders Affected

• DHS and CWMD Office: Directly tasked with implementation, gaining expanded responsibilities and possibly additional funding.
• Law Enforcement and Border Agencies: Benefit from integrated WMD protocols for fentanyl interdiction at ports and borders.
• Public Health Organizations: Could see indirect support through enhanced prevention programs, though the focus is more on security than treatment.
• Citizens and Communities: Particularly those impacted by the opioid epidemic, including victims of overdoses and families; drug traffickers and producers face heightened scrutiny.
• International Partners: Countries like Mexico or China, key in fentanyl supply chains, may experience altered U.S. policy approaches.

Notable Legal, Constitutional, or Political Implications

• Legal: Broadens the interpretation of "WMD" under federal law without defining new penalties, potentially allowing CWMD tools (e.g., advanced detection tech) to be repurposed for drug enforcement; may raise questions about statutory fit, as fentanyl is not a traditional weapon.
• Constitutional: Aligns with Congress's authority over national security and commerce but could spark debates on federal overreach into state-level drug policy or Fourth Amendment concerns if it expands surveillance powers.
• Political: Frames the fentanyl crisis as a national security issue, which may garner bipartisan support for anti-drug measures but could politicize public health responses; introduced in the 119th Congress (2025), it reflects ongoing congressional focus on border security and opioids.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Boebert, Lauren [R-CO-4]

Cosponsors (12)

Rep. Nehls, Troy E. [R-TX-22], Rep. Miller, Mary E. [R-IL-15], Rep. Donalds, Byron [R-FL-19], Rep. Ogles, Andrew [R-TN-5], Rep. Moore, Barry [R-AL-1], Rep. Burchett, Tim [R-TN-2], Rep. Luna, Anna Paulina [R-FL-13], Rep. Van Duyne, Beth [R-TX-24], Rep. McDowell, Addison [R-NC-6], Rep. Begich, Nicholas J. [R-AK-At Large], Rep. Shreve, Jefferson [R-IN-6], Rep. Houchin, Erin [R-IN-9]

Recent Actions

• 2025-01-03: Referred to the Subcommittee on Emergency Management and Technology.
• 2025-01-03: Referred to the House Committee on Homeland Security.
• 2025-01-03: Introduced in House
• 2025-01-03: Introduced in House

Bill Versions

• Fentanyl is a WMD Act — issued 2025-01-03 — PDF (2 pages)